However, faster is not always better
It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction
Ozempic is a GLP-1 receptor agonist, while Tirzepatide is a dual-acting drug
With that weight loss comes lower cholesterol levels and improved blood pressure and blood sugar, all contributing to lower cardiovascular risk
At Aspire MedSpa, Rosaly Stephens, ARNP-C , and our clinical team are committed to ensuring you feel informed and supported from the moment of your very first injection
Metabolic goals semaglutide still provides strong benefits for blood sugar and heart health